Abstract: The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the following formula, or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or prodrug thereof:
wherein R1, R2 and B1 are as defined herein.
Type:
Grant
Filed:
December 6, 2002
Date of Patent:
August 17, 2004
Assignee:
Bristol-Myers Squibb Company
Inventors:
Michael A. Walker, Jacques Banville, Roger Remillard, Serge Plamondon